Economy

Regeneron Pharmaceuticals, Inc. (REGN) Stake Lessened by Zurcher Kantonalbank Zurich Cantonalbank

Regeneron Pharmaceuticals, Inc. (REGN) Stake Lessened by Zurcher Kantonalbank Zurich Cantonalbankā€

Therefore 25% are positive. Umpqua Holdings Corp had 19 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has "Buy" rating by Zacks given on Tuesday, August 18. BidaskClub cut Regeneron Pharmaceuticals from a "strong-buy" rating to a "buy" rating in a report on Thursday, July 6th. The firm has "Hold" rating by Cowen & Co given on Monday, July 31. The stock presently has an average rating of "Hold" and an average target price of $496.35. As per Monday, July 10, the company rating was maintained by Keefe Bruyette & Woods. The firm earned "Buy" rating on Monday, June 12 by Leerink Swann.

The stock of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is a huge mover today! About 548,867 shares traded.

Regeneron Pharmaceuticals (NASDAQ:REGN) last released its earnings results on Thursday, August 3rd.

Schroder Investment Management Group decreased Regeneron Pharmaceuticals Incorporated Common Stock Usd0.001 (REGN) stake by 13.42% reported in 2016Q4 SEC filing. $1.35 million worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) was sold by STAHL NEIL on Thursday, June 1. On average, analysts predict that Regeneron Pharmaceuticals, Inc. will post $14.90 EPS for the current fiscal year.

08/04/2017 - Regeneron Pharmaceuticals, Inc. had its "buy" rating reiterated by analysts at UBS. Therefore 100% are positive. Regeneron Pharmaceuticals has a 52-week low of $325.35 and a 52-week high of $452.96. They now have a Dollars 475 price target on the stock. Robert W. Baird maintained Regeneron Pharmaceuticals Inc (NASDAQ:REGN) rating on Thursday, September 7. The stock has "Outperform" rating by RBC Capital Markets on Friday, January 6.

COPYRIGHT VIOLATION NOTICE: "Regeneron Pharmaceuticals (REGN) Receiving Somewhat Favorable Media Coverage, Study Finds" was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. The stock has "Outperform" rating by BMO Capital Markets on Tuesday, April 12.

In related news, EVP Robert J. Terifay sold 21,147 shares of the company's stock in a transaction dated Friday, June 16th. Blackrock Grp has invested 0.11% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). TD Securities has "Buy" rating and $70 target. On Tuesday, June 20 the stock rating was maintained by Piper Jaffray with "Buy". As per Friday, February 5, the company rating was initiated by Leerink Swann. TD Securities maintained Snc-Lavalin Group Inc (TSE:SNC) rating on Thursday, August 11.

Since March 29, 2017, it had 1 insider buy, and 8 insider sales for $42.35 million activity. Given that liquidity is king in short-term, CASC is a stock with 49.55 million shares outstanding that normally trades 4.6% of its float. GOLDSTEIN JOSEPH L also sold $482,550 worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) on Friday, June 9. Sanofi bought 136,050 shares worth $65.06 million. The Polen Capital Management Llc holds 1.34 million shares with $492.14M value, up from 811,301 last quarter. John G Ullman And Inc stated it has 0.07% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). The company has market cap of $84.91 million. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. It has a 14.48 P/E ratio. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion.

The institutional investor owned 16,358 shares of the biopharmaceutical company's stock after selling 1,298 shares during the period. Its up 0.29, from 0.96 in 2016Q3. Hsbc Holdings PLC raised its stake in shares of Regeneron Pharmaceuticals by 16.9% in the third quarter. Tarbox Grp owns 18 shares. Symphony Asset Ltd Liability invested in 1,197 shares. Advsrs Asset Mngmt Inc stated it has 0.04% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Mirae Asset Glob Comm Ltd stated it has 1,941 shares. After $3.88 actual earnings per share reported by Regeneron Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts -2.32% negative EPS growth. Korea Investment CORP raised its holdings in shares of Regeneron Pharmaceuticals by 223.9% during the 1st quarter. Cubist Systematic Strategies Ltd Liability holds 0.06% or 1,971 shares.

08/04/2017 - Regeneron Pharmaceuticals, Inc. had its "neutral" rating reiterated by analysts at JP Morgan. Louisiana State Employees Retirement Sys accumulated 4,800 shares or 0.09% of the stock. Leavell Investment Management, a Alabama-based fund reported 3,440 shares. Seizert Capital Partners Llc, a Michigan-based fund reported 10,073 shares. Jennison Associates LLC raised its stake in shares of Regeneron Pharmaceuticals by 4.5% in the third quarter. BlackRock Group LTD now owns 616,217 shares of the biopharmaceutical company's stock valued at $247,730,000 after buying an additional 17,764 shares during the last quarter. Rhumbline Advisers owns 128,308 shares or 0.12% of their USA portfolio. The shares were sold at an average price of $429.34, for a total transaction of $858,680.00. About shares traded. Fate Therapeutics Inc (NASDAQ:FATE) has risen 166.12% since September 15, 2016 and is uptrending. It has underperformed by 5.81% the S&P500.



Like this

Latest


15 September 2017
Fayose: no apology for adopting my deputy
If you conduct an opinion poll today, that does not favour us because of the actions and inactions of this government. But responding to the allegation, Fayose said he would not engage in pettiness and respond to unproductive issues.

15 September 2017
Lawmakers React to Potential Deal Between Trump and Democrats Over DACA
Schumer told a colleague that he told Trump that "you're much better off if you can sometimes step right and sometimes step left". Schumer and Pelosi reiterated their opposition to the wall, and Democrats in the past have promised to block funding for it.

15 September 2017
Predator gets 31 years for brutal killing of teenagerEllen Higginbottom
He said: 'You Mark Buckley had entered the park intending, as I find, upon attacking and sexually assaulting a female. Judge David Stockdale QC, told Buckley he subjected Miss Higginbottom to "a savage and brutal attack".

15 September 2017
Independent Catalonia would need to apply to join EU: Juncker
Speaking to German broadcaster ARD , the German finance minister hailed in principle the objective of extending the single currency across all member states.

15 September 2017
US Retail Sales Fell in August
Retail sales fell in August as the automobile, electronics and clothing categories all fell back during the month. There was a 0.3% increase in food and drinking places which should sustain confidence in discretionary spending.

15 September 2017
Brokers Change Their Target Price On Novo Nordisk A/S (NYSE:NVO)
Several large investors have recently bought and sold shares of the stock. 77 funds opened positions while 488 raised stakes. The share price of Novo Nordisk A/S (NYSE: NVO ) was down -0.05% during the last trading session, with a day high of 48.70.

15 September 2017
Vantiv, Inc. (VNTV) Research Coverage Started at Bank of America Corporation
Perhaps, that suggests something about why 46.75% of the outstanding share supply is held by institutional investors. Vantiv, Inc. (NYSE:VNTV) closed September 14 at $72.15, down -1.35% or $0.99 from its record high price of $73.14.

15 September 2017
Oppenheimer Asset Management Inc. Grows Stake in Workday, Inc. (WDAY)
The total amount of shares outstanding is 211.70 million, giving the company a market capitalization of about 22.65 billion. Considering that the stock daily volume of 5.55 million shares, this represents a pretty noteworthy shoot in volume.

15 September 2017
Hurricane Irma: What The UK Military Has Done So Far
The Department for International Aid denied that its response to the crisis had been affected by any budgetary considerations. The UK is committed to spending 0.7% of national income on aid under the rules set by the OECD.

15 September 2017
Oasis Petroleum Inc. (NYSE:OAS): Are Traders Shorting This Stock?
Finally, Raymond James Financial Services Advisors Inc. increased its position in Oasis Petroleum by 374.7% in the fourth quarter. July 13 investment analysts at Citigroup held the company rating at "Buy" and moved down the price target to $13.00 from $14.00.



Recommended